Skip to content

Evidence-based Laboratory Test Order Sets in Primary Care

The Effect of Evidence-based Order Sets Within a CPOE System on the Quantity and Quality of Laboratory Test Ordering in Family Practice: a Cluster Randomised Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02950142
Enrollment
288
Registered
2016-10-31
Start date
2017-12-01
Completion date
2019-08-01
Last updated
2020-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Anemia, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus, Diarrhea, Fatigue, General Check-up, Gout, Hypertension, Liver Diseases, Lung Embolism, Medication Monitoring, Obesity, Rheumatoid Arthritis, Sexually Transmitted Diseases, Thyroid Diseases

Keywords

order sets, decision support, laboratory test, primary care

Brief summary

Cluster randomised controlled trial to evaluate what the effect is of evidence-based order sets aimed at five indications on the appropriateness of laboratory test ordering in primary care.

Detailed description

Cluster randomised controlled trial in Belgian primary care practices. Participants will be primary care physicians working in primary care practices affiliated to one of three collaborating laboratories in the Leuven, Ghent or Antwerp regions. Primary care practices will be allocated and randomized to either the intervention or control group. Physicians in PCPs randomized to the intervention will be offered order sets based on indication when using the CPOE for ordering laboratory tests. The effect of order sets will be analyzed for 17 common indications for ordering laboratory tests in Belgian primary care: diabetes mellitus, hypertension, cardiovascular disease, general check-up, unexplained fatigue, anemia, liver pathology, medication monitoring, gout, chronic kidney disease, lung embolism, acute coronary syndrome, diarrhea, thyroid disease, sexually transmitted disease, rheumatoid arthritis and obesity.

Interventions

OTHERCPOE with order sets for lab testing

CPOE including series of recommended tests ordered per indication

OTHERCPOE without order sets for lab testing

CPOE only

Sponsors

KU Leuven
CollaboratorOTHER
University Ghent
CollaboratorOTHER
Norwegian Institute of Public Health
CollaboratorOTHER_GOV
Sciensano
CollaboratorOTHER_GOV
Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Primary care practices will be considered eligible if all the physicians active in the practice agree to be involved in the study * All family physicians will be considered eligible if they: * Collaborate with either MCH, Anacura or AML for their laboratory test orders * Agree to use the online CPOE for their laboratory test orders * Use a computerized EHR for patient care * Agree to the terms in the informed consent

Exclusion criteria

* Primary care practices where one or more physicians refuse to be enrolled will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Appropriateness3 monthsnumber of appropriate tests for 17 study indications

Secondary

MeasureTime frameDescription
Missed or delayed diagnoses1 yearIncidence of missed or delayed diagnoses after laboratory test
Laboratory test volume1 yearTotal volume of ordered laboratory tests

Other

MeasureTime frameDescription
Downstream or cascade clinical activities1 yearAll downstream or cascade clinical activities as a result of abnormal test result

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026